IQVIA

Category

Walter and Eliza Institute’s Virtual Tech-based Study Investigating use of Hydroxychloroquine to Protect Frontline Health Workers from COVID-19

The Walter and Eliza Institute of Medical Research, a leading biomedical research center in Australia, recently selected U.S.-based, multinational IQVIA (NYSE: IQV)—the world’s largest clinical research organization or CRO—to manage COVID SHIELD, a Phase II/III...

IQVIA & Quest Diagnostics Joint Venture Q² Solutions Partner with University of Texas Medical Branch (UTMB) Targeting COVID-19 Vaccines

An IQVIA and Quest Diagnostics joint venture known as Q2 Solutions, which focuses on clinical trial laboratory services, has announced a collaboration with the University of Texas Medical Branch (UTMB) to develop a novel assay for COVID-19 tests, a key tool necessary...

Assistance Publique – Hôpitaux de Paris Inks Partnership with IQVIA for a ‘Prime Site’ in Europe

One of Europe’s leading clinical research centers, Assistance Publique – Hôpitaux de Paris (AP-HP), has joined forces with IQVIA, the global health technology, and human data science company to launch the Paris Prime Site for clinical trials. This AP-HP partnership...

Pin It on Pinterest